Insulin therapy and in-hospital mortality in critically ill patients: Systematic review and meta-analysis of randomized controlled trials

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue 2, 2006, Pages 164-172

  Pittas, Anastassios G ^a,b   Siegel, Richard D ^a   Lau, Joseph ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b Division of Endocrinology Diabetes and Hypertension   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE INSULIN POTASSIUM SOLUTION; INSULIN; UNCLASSIFIED DRUG; GLUCOSE; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION; POTASSIUM;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONFERENCE PAPER; CRITICALLY ILL PATIENT; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TREATMENT INDICATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MEDLINE; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIA; INSULIN; MEDLINE; POTASSIUM; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS;

EID: 33745482771     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607106030002164     Document Type: Conference Paper

References (60)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
2. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207-214.
3. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
4. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
5. Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(suppl 2):4-9.
6. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164:2005-2011.
7. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med. 1997;127: 380-387.
8. Balk EM, Bonis PA, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA. 2002;287:2973-2982.
9. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282: 1054-1060.
10. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820-826.
11. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet. 1998;351:123-127.
12. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53:207-216.
13. Tang JL, Liu JL. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol. 2000;53:477-484.
14. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004;292:1363-1364.
15. van der Horst IC, Zijlstra F, van't Hof AW, et al. Glucose-insulin- potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol. 2003;42:784-791.
16. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10(suppl 2):46-52.
17. Fache J, Kastrati A, Mehilli J, et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J. 2004;148:e3.
18. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
19. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
20. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497-1502.
21. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-150.
22. Mittra B. Potassium, glucose, and insulin in treatment of myocardial infarction. Lancet. 1965;2:607-609.
23. Lundman T, Orinius E. Insulin-glucose-potassium infusion in acute myocardial infarction. Acta Med Scand. 1965;178:525-528.
24. Autio L, Hakkila J, Hartel G, Ikkala E. Anticoagulants and Sodi-Pallares infusion in acute myocardial infarction. Acta Med Scand. 1966;179:355-360.
25. Sievers J, Lindh J, Johansson BW, Karnell J. Acute myocardial infarction treated by glucose-insulin-potassium (GIK) infusion. Cardiology. 1966;49:239-247.
26. Malach M. Polarizing solution in acute myocardial infarction. Am J Cardiol. 1967;20:363-366.
27. Pilcher J, Etishamuding M, Exon P, Moore J. Potassium, glucose and insulin in myocardial infarction. Lancet. 1967;1:1109.
28. Potassium, glucose, and insulin treatment for acute myocardial infarction. Lancet. 1968;2:1355-1360.
29. Pentecost BL, Mayne NM, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet. 1968;1:946-948.
30. Iisalo E, Kallio V. Potassium, glucose and insulin in the treatment of acute myocardial infarction. Curr Ther Res Clin Exp. 1969;11:209-215.
31. Hjermann I. A controlled study of peroral glucose, insulin and potassium treatment in myocardial infarction. Acta Med Scand. 1971;190:213-218.
32. Prather JW, Russell RO Jr, Mantle JA, McDaniel HG, Rackley CE. Metabolic consequences of glucose-insulin-potassium infusion in treatment of acute myocardial infarction. Am J Cardiol. 1976;38:95-99.
33. Heng MK, Norris RM, Singh BN, Barratt-Boyes C. Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J. 1977;39:748-757.
34. Lolley DM, Ray JF 3rd, Myers WO, Sheldon G, Sautter RD. Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement: prospective randomized study. Ann Thorac Surg. 1978;26:515-524.
35. Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO Jr, Rackley CE. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction: effects on myocardial hemodynamics, substrates and rhythm. Am J Cardiol. 1979;43:801-809.
36. Salerno TA, Wasan SM, Charrette EJ. Glucose substrate in myocardial protection. J Thorac Cardiovasc Surg. 1980;79:59-62.
37. Mantle JA, Rogers WJ, Smith LR, et al. Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. Am Heart J. 1981;102(3 pt 1):313-324.
38. Whitlow PL, Rogers WJ, Smith LR, et al. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol. 1982;49:811-820.
39. Oldfield GS, Commerford PJ, Opie LH. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. J Thorac Cardiovasc Surg. 1986;91:874-878.
40. Gradinac S, Coleman GM, Taegtmeyer H, Sweeney MS, Frazier OH. Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg. 1989;48:484-489.
41. Davies RR, Newton RW, McNeill GP, Fisher BM, Kesson CM, Pearson D. Metabolic control in diabetic subjects following myocardial infarction: difficulties in improving blood glucose levels by intravenous insulin infusion. Scott Med J. 1991;36:74-76.
42. Brodin LA, Dahlgren G, Ekestrom S, Settergren G, Ohqvist G. Influence of glucose-insulin-potassium on left ventricular function during coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg. 1993;27:27-34.
43. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
44. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Shemin RJ, Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1997;113:354-360.
45. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction: the ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation. 1998;98:2227-2234.
46. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999;13:191-200.
47. Besogul Y, Tunerir B, Aslan R, Isiksoy S, Colak O, Rural T. Clinical, biochemical and histochemical assessment of pretreatment with glucose-insulin-potassium for patients undergoing mitral valve replacement in the third and fourth functional groups of the New York Heart Association. Cardiovasc Surg. 1999;7:645-650.
48. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-799.
49. Szabo Z, Arnqvist H, Hakanson E, Jorfeldt L, Svedjeholm R. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with type II diabetes. Clin Sci (Lond). 2001;101:37-43.
50. Ulgen MS, Alan S, Akdemir O, Toprak N. The effect of glucose-insulin- potassium solution on ventricular late potentials and heart rate variability in acute myocardial infarction. Coronary Artery Dis. 2001;12:507-512.
51. Lell WA, Nielsen VG, McGiffin DC, Schmidt FE Jr, Kirklin JK, Stanley AW Jr. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg. 2002;73:1246-1251.
52. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen G. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002;123:928-935.
53. Smith A, Grattan A, Harper M, Royston D, Riedel BJ. Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study. J Cardiothorac Vasc Anesth. 2002;16:413-420.
54. Groban L, Butterworth J, Legault C, Rogers AT, Kon ND, Hammon JW. Intraoperative insulin therapy does not reduce the need for inotropic or antiarrhythmic therapy after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2002;16:405-412.
55. The IMMEDIATE trial. Available at: http://www.clinicaltrials. gov/ct/gui/show/NCT00091507. Accessed July 1, 2005.
56. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
57. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;49:531-537.
58. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993;22:1788-1794.
59. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
60. Krebs JD, Robinson GM, Smith RB, Toomath RJ. Follow up testing of hyperglycaemia during hospital admission: combined use of fasting plasma glucose and HbA1c. N Z Med J. 2000;113:379-381.